YAP1 and breast cancer: To further test the impact of phosphoinositide binding to YAP in breast cancer cell motility, endogenous YAP was depleted by siRNAs targeting the 3’UTR and then rescued with WT, 2Q, or 3Q YAP by ectopic expression of the ORF-expressing constructs and cell motility was measured.